home / openregs / federal_register

federal_register: 2013-27406

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2013-27406 Public Workshop: Follow-On Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition Notice The Federal Trade Commission ("FTC" or "Commission") announces it will hold a workshop to explore competition issues involving biologic medicines and follow-on biologics. The workshop will focus on the potential impact of state regulations and naming conventions on such competition, including how regulations may be structured to facilitate competition while still protecting patient health and safety. The experience of developing follow-on competition from small-molecule generic drugs will be considered and, as relevant, compared. Topics will include the circumstances under which potential entrants would be willing to invest in the development of follow-on biologics in order to use the abbreviated regulatory approval pathway created by federal legislation. The workshop will also survey the experience of other countries with regulatory systems that enable follow-on biologic competition. This Notice poses a series of questions about which the FTC seeks public comment. The FTC will take these comments into account in its examination of these topics. 2013-11-15 2013 11 https://www.federalregister.gov/documents/2013/11/15/2013-27406/public-workshop-follow-on-biologics-impact-of-recent-legislative-and-regulatory-naming-proposals-on https://www.govinfo.gov/content/pkg/FR-2013-11-15/pdf/2013-27406.pdf Federal Trade Commission 192 The Federal Trade Commission ("FTC" or "Commission") announces it will hold a workshop to explore competition issues involving biologic medicines and follow-on biologics. The workshop will focus on the potential impact of state regulations and naming...  

Links from other tables

  • 1 row from document_number in federal_register_agencies
  • 1 row from fr_document_number in fr_regs_crossref
Powered by Datasette · Queries took 0.74ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API